Drug Development Support for the Cancer Therapy Evaluation Program

Notice ID:

75N91021R00043

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

NIH NCI

Office:

NIH NCI

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

nov 19, 2021 04:25 pm est

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

nov 16, 2021 01:00 pm est

Inactive Policy:

manual

Updated Inactive Date:

jun 30, 2022

Original Inactive Date:

jun 30, 2022

Initiative:

• None***--***

Product Service Code:

an13 - health r&d services; health care services; experimental development

NAICS Code:

541715 - research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

Original Set Aside:

Title: Drug Development Support for the Cancer Therapy Evaluation Program (CTEP) See the attached solicitation/RFP for more information. The deadline for receipt of proposals is extended to 2pm ET on November 30, 2021. See attached Amendment 00002 for details.

OFFICE OF ACQUISITIONS 6011 EXECUTIVE BLVD.SUITE 501

ROCKVILLE , MD 20852

USA

Primary Point of Contacts:

DeChanta Vaughan, Contract Specialist

Secondary Point of Contact:

Pooja Rathore